期刊文献+

结合雌激素阴道软胶囊质量研究

The Study of the Quality of Conjugated Estrogens Vaginal Soft Capsule
原文传递
导出
摘要 目的建立结合雌激素阴道软胶囊(Conjugated Estrogens vaginal soft capsule)质量标准。方法采用高效液相色谱法测定结合雌激素阴道软胶囊含量;检查其崩解、融变时限,并与参比制剂进行对比研究。结果马烯雌酮硫酸钠和雌酮硫酸钠分别在2.02~10.09μg、4.03~20.16μg内呈良好的线性关系(r=0.9999),马烯雌酮硫酸钠3个浓度回收率分别为100.0%,101.3%和99.4%,雌酮硫酸钠3个浓度回收率分别为99.0%,99.4%和101.8%。结合雌激素阴道软胶囊崩解、融变时限与参比制剂间无差异(P>0.05)。结论本法专属性强,重复性、精密度好,结果准确可靠,可作为结合雌激素阴道软胶囊的质量控制方法。 OBJECTIVE The purpose of the research is to establish the quality standard of conjugated estrogens (CE) vaginal soft capsule. METHODS The HPLC method was conducted for the determination of the content of CE vaginal soft capsule. The disintegration of CE vaginal soft capsule was detected and the indicators were compared between CE vaginal soft capsule and the reference preparation. RESULTS There was good linearity of sodium estrone sulfate and sodium equilin sulfate in the range of 2.02-10.09 μg and 4.03-20.16 μg (r=0.999 9), the recovery of three kinds content were 100.0%, 101.3%, 99.4% and 99.0%, 99.4%, 101.8%. CE vaginal soft capsules were examined, there was no difference between these indicators and those of the reference preparation. CONCLUSION The method is specific, reliable and accurate. It can be used for the quality control of CE vaginal soft capsule effectively.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2009年第11期951-954,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 结合雌激素 阴道软胶囊 质量研究 conjugated estrogens vaginal soft capsule quality standard
  • 相关文献

参考文献5

二级参考文献30

  • 1白琳.阴道使用雌三醇栓治疗绝经后妇女反复泌尿系感染的临床研究[J].中国综合临床,2004,20(12):1139-1140. 被引量:6
  • 2金毓翠 王迪钧 曹霖 等.治疗妇科疾病用局部给药缓释装置[P].中国专利CN2416900Y.2001-1-31.
  • 3Woolfson AD, Elliott GRE, Gilligan CA, et al. Design of an intravaginal ring for the controlled delivery of 17β-estrediol as its 3-acetate ester [J]. J Controlled Release, 1999,61:319.
  • 4Chang JY, Oh YK, Choi HG, et al . Rheologlcal evaluation of thevrnosensifive and mucoadhesive vaginal gels in physiological conditions [J]. Int J Pharm, 2002, 241(1): 155.
  • 5Gagne N, Cormier H, Omar RF, et al. Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9 [ J ]. Sex Transm Dis, 1999,26:177.
  • 6Livengood CH, Seper DE, Sheeham KL, et al. Comparison of once -daily and twice-daily dosing of 0.75% metrinidasole gel in the treatment of bacterial vaginosis [J]. Sex Transm Dis, 1999,26:137.
  • 7Valenta C, Marschutz M, Egyed C,et al. Evaluation of the inhibition effect of thiolated poly ( acrylates ) on vaginal membrane and release of the model drug LH-RH[J]. J Pharm Pharmacol,2002,54(5) : 603.
  • 8Chanrachakul B, Herabutya Y, Punyavachira P. Randimized comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term [J]. Obstet Gynecol, 2000,9(4) :549.
  • 9Digenis GA, Nosek MF, Darwazeh NB, et al. Novel vaginal controlled-delivery systems incorporating coprecipotates of nonoxynol-9 [J]. Pharm Dev Technol, 1999,4:421.
  • 10Manonai J, Theppisai U, Chittaeharoen A. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms [J]. J Med Assoc Thai, 2001,84(7) :1015.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部